Fisher & Paykel Healthcare announced today that it has filed a complaint with the US International Trade Commission (ITC), seeking an exclusion order to prevent the importation and sale of ResMed’s AirFit P10 range of nasal pillows masks in the United States.
The company alleges that ResMed’s AirFit P10 masks, AirFit P10 for Her masks and AirFit P10 for AirMini masks, which are used in the treatment of obstructive sleep apnea (OSA), infringe five Fisher & Paykel Healthcare patents. The company is therefore seeking a permanent exclusion order and cease and desist order from the ITC to prevent the sale and importation of the AirFit P10 range of masks in the US.
Lewis Gradon, Fisher & Paykel Healthcare Managing Director and Chief Executive Officer, said “Over the past 20 years, Fisher & Paykel Healthcare has built a significant portfolio of more than 2,000 issued and pending patents. We have developed unique mask technology that has provided improved care and outcomes for patients with OSA and we take infringement of our intellectual property rights very seriously.”
The company advises that the earnings guidance for its 2019 financial year results, as provided on 3 September 2018, remains unchanged as the legal costs of this additional action were allowed for at that time.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.